ArticleIn silico pharmacology2021

In silico studies of Potency and safety assessment of selected trial drugs for the treatment of COVID-19.

Peter Ifeoluwa Adegbola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.